IGC Pharma (IGC) Return on Invested Capital (2011 - 2023)
IGC Pharma (IGC) posted quarterly Return on Invested Capital of 20.38% for Q1 2023, down 1942.0% year-over-year from 1.11% in Q1 2022, and down 8.24% quarter-over-quarter from 18.83% in Q4 2022.
IGC Pharma (IGC) Return on Invested Capital (2011 - 2023) Analysis & Trends
IGC Pharma (IGC) has reported Return on Invested Capital for 10 consecutive years, with 20.38% the latest figure, recorded in Q1 2023.
- In Q1 2023, Return on Invested Capital fell 1942.0% year-over-year to 20.38%; the TTM figure through Mar 2023 stood at 20.38% (down 1942.0% YoY), while the FY2022 annual figure was 1.01%, changed N/A from the prior year.
- Return on Invested Capital slipped to 20.38% in Q1 2023 per IGC's latest filing, from 18.83% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.14% in Q4 2020 and bottomed at 20.38% in Q1 2023.
- Historically, Return on Invested Capital has averaged 7.55% across 3 years, with a median of 0.95% in 2022.
- On a YoY basis, Return on Invested Capital climbed as much as 1942 bps in 2023 and fell as far as 1942 bps in 2023.
- IGC Pharma's Return on Invested Capital stood at 0.14% in 2020, then plunged by 13464 bps to 18.83% in 2022, then slipped by 8 bps to 20.38% in 2023.
- Business Quant data shows IGC's Return on Invested Capital at 20.38% in Q1 2023, 18.83% in Q4 2022, and 13.55% in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -20.38% |
| Dec 31, 2022 | -18.83% |
| Sep 30, 2022 | -13.55% |
| Jun 30, 2022 | -13.41% |
| Mar 31, 2022 | -0.95% |
| Dec 31, 2020 | -0.14% |
| Sep 30, 2020 | -0.22% |
| Jun 30, 2020 | -0.25% |
| Mar 31, 2020 | -0.20% |
| Mar 31, 2017 | -0.04% |
| Dec 31, 2016 | -0.02% |
| Sep 30, 2016 | -0.02% |
| Jun 30, 2016 | -0.01% |
| Mar 31, 2016 | -0.01% |
| Dec 31, 2015 | -0.01% |
| Sep 30, 2015 | -0.01% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | -0.02% |
| Dec 31, 2014 | -0.03% |
| Sep 30, 2014 | -0.04% |